Nedocromil sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for nedocromil sodium and what is the scope of freedom to operate?
Nedocromil sodium
is the generic ingredient in three branded drugs marketed by King Pharms Llc, Allergan, Epic Pharma Llc, and Sanofi Aventis Us, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for nedocromil sodium. One supplier is listed for this compound.
Summary for nedocromil sodium
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 4 |
NDAs: | 4 |
Drug Master File Entries: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 43 |
Clinical Trials: | 7 |
Patent Applications: | 5,834 |
What excipients (inactive ingredients) are in nedocromil sodium? | nedocromil sodium excipients list |
DailyMed Link: | nedocromil sodium at DailyMed |
Recent Clinical Trials for nedocromil sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Indiana University | Phase 4 |
Childhood Asthma Research and Education Network | Phase 3 |
Imperial College London | Phase 2 |
Pharmacology for nedocromil sodium
Drug Class | Mast Cell Stabilizer |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for nedocromil sodium
Anatomical Therapeutic Chemical (ATC) Classes for nedocromil sodium
US Patents and Regulatory Information for nedocromil sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | NEDOCROMIL SODIUM | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 090638-001 | Aug 22, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | TILADE | nedocromil sodium | SOLUTION;INHALATION | 020750-001 | Oct 1, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
King Pharms Llc | TILADE | nedocromil sodium | AEROSOL, METERED;INHALATION | 019660-001 | Dec 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for nedocromil sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pharms Llc | TILADE | nedocromil sodium | AEROSOL, METERED;INHALATION | 019660-001 | Dec 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Allergan | ALOCRIL | nedocromil sodium | SOLUTION/DROPS;OPHTHALMIC | 021009-001 | Dec 8, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.